 |
|
 |
| |
 |
|
Class Information
Number: 530/300
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Peptides of 3 to 100 amino acid residues
Description: Compounds consisting of three or more amino acids joined covalently by peptide bonds.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 530/327 |
11 to 14 amino acid residues in defined sequence |
1,909 |
| 530/326 |
15 to 23 amino acid residues in defined sequence |
2,339 |
| 530/325 |
24 amino acid residues in defined sequence |
1,001 |
| 530/324 |
25 or more amino acid residues in defined sequence |
3,642 |
| 530/330 |
4 to 5 amino acid residues in defined sequence |
1,741 |
| 530/329 |
6 to 7 amino acid residues in defined sequence |
1,586 |
| 530/328 |
8 to 10 amino acid residues in defined sequence |
2,193 |
| 530/316 |
Angiotensin; related peptides |
61 |
| 530/314 |
Bradykinin; kallidin; related peptides |
66 |
| 530/307 |
Calcitonin; related peptides |
179 |
| 530/345 |
Chemical aftertreatment, e.g., acylation, methylation, etc. |
859 |
| 530/332 |
Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc. |
316 |
| 530/306 |
Corticotropin (atch); related peptides |
59 |
| 530/317 |
Cyclic peptides |
1,201 |
| 530/302 |
Endorphin and enkephalin; related peptides |
177 |
| 530/308 |
Glucagon; related peptides |
145 |
| 530/310 |
Gramicidin or tyrocidin; related peptides |
8 |
| 530/303 |
Insulin; related peptides |
486 |
| 530/313 |
Lutenizing hormone releasing factor (lrf); related peptides |
264 |
| 530/312 |
Melanotropin (msh) or eledoisin; related peptides |
38 |
| 530/315 |
Oxytocin; vasopressin; related peptides |
91 |
| 530/322 |
Peptides containing saccharide radicals, e.g., bleomycins, etc. |
520 |
| 530/323 |
Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc. |
394 |
| 530/309 |
Secretin or gastrin; related peptides |
48 |
| 530/344 |
Separation or purification |
456 |
| 530/311 |
Somatostatin (srif); related peptides |
269 |
| 530/333 |
Synthesis of peptides |
725 |
| 530/301 |
Thymopoietin or lipotropin; related peptides |
42 |
| 530/331 |
Tripeptides, e.g., tripeptide thyroliberin (trh), melanostatin (mif), etc. |
1,474 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| RE40988 |
Ligands of the neuropeptide receptor HFGAN72 |
Nov. 17, 2009 |
| 7619061 |
Antigen constructs useful in the detection and differentiation of antibodies to HIV |
Nov. 17, 2009 |
| 7619058 |
Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
Nov. 17, 2009 |
| 7619057 |
MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
Nov. 17, 2009 |
| 7618939 |
Compositions and methods to prevent cancer with cupredoxins |
Nov. 17, 2009 |
| 7618937 |
Peptidomimetic polymers for antifouling surfaces |
Nov. 17, 2009 |
| 7618782 |
Methods of diagnosing muscle damage |
Nov. 17, 2009 |
| 7618653 |
Biological artificial nerve guide and method of making |
Nov. 17, 2009 |
| 7618637 |
Heat shock protein-based vaccines and immunotherapies |
Nov. 17, 2009 |
| 7618636 |
Antigenic meningococcal peptides |
Nov. 17, 2009 |
| 7618635 |
Super-antigen fusion proteins and the use thereof |
Nov. 17, 2009 |
| 7618634 |
Neurotoxic oligomers |
Nov. 17, 2009 |
| 7615614 |
Antigen constructs useful in the detection and differentiation of antibodies to HIV |
Nov. 10, 2009 |
| 7615613 |
Antigen constructs useful in the detection and differentiation of antibodies to HIV |
Nov. 10, 2009 |
| 7615533 |
TPO peptide compounds for treatment of anemia |
Nov. 10, 2009 |
| 7615530 |
Immunogenic compositions and methods of use |
Nov. 10, 2009 |
| 7615527 |
Peptides which modulate blood coagulation and methods of use thereof |
Nov. 10, 2009 |
| 7612190 |
Method for targeting a polypeptide onto cellular surface |
Nov. 3, 2009 |
| 7612162 |
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response |
Nov. 3, 2009 |
| 7612043 |
Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2 |
Nov. 3, 2009 |
| 7611720 |
Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
Nov. 3, 2009 |
| 7611713 |
Inducing cellular immune responses to hepatitis B virus using peptide compositions |
Nov. 3, 2009 |
| 7608696 |
IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Oct. 27, 2009 |
| 7608691 |
Antibodies against IL-16 antagonist peptides |
Oct. 27, 2009 |
| 7608686 |
Human tumor necrosis factor receptor |
Oct. 27, 2009 |
| 7608685 |
Tumor antigen based on products of the tumor suppressor gene WT1 |
Oct. 27, 2009 |
| 7608684 |
Soluble CD14 antigen |
Oct. 27, 2009 |
| 7608683 |
Stress proteins and peptides and methods of use thereof |
Oct. 27, 2009 |
| 7608682 |
Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
Oct. 27, 2009 |
| 7608681 |
Methods and compositions for prolonging elimination half-times of bioactive compounds |
Oct. 27, 2009 |
| 7608582 |
Delivery vehicle comprising a modified MscL protein channel |
Oct. 27, 2009 |
| 7608581 |
Biofunctional, antimicrobial coatings for medical devices |
Oct. 27, 2009 |
| 7608577 |
Peptidyl ketones as inhibitors of DPIV |
Oct. 27, 2009 |
| 7608405 |
Method of selectively assaying adiponectin multimers |
Oct. 27, 2009 |
| 7608404 |
Disease determination method, data generation method for disease determination and data generation system for disease determination |
Oct. 27, 2009 |
| 7608277 |
Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
Oct. 27, 2009 |
| 7608256 |
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
Oct. 27, 2009 |
| 7605248 |
Recombinant constructs of Borrelia burgdorferi |
Oct. 20, 2009 |
| 7605121 |
Oligopeptide lyophilisate, their preparation and use |
Oct. 20, 2009 |
| 7604954 |
Method for evaluating kidney function in a feline |
Oct. 20, 2009 |
| 7604810 |
Conserved Neisserial antigens |
Oct. 20, 2009 |
| 7601810 |
Insecticidal plant cyclotide with activity against homopteran insects |
Oct. 13, 2009 |
| 7601807 |
Protease, DNA encoding the same, and method for manufacturing protease |
Oct. 13, 2009 |
| 7601800 |
Compositions and methods for monitoring breast cancer treatment |
Oct. 13, 2009 |
| 7601799 |
Methods and means to promote gut absorption |
Oct. 13, 2009 |
| 7601691 |
Anti-obesity agents |
Oct. 13, 2009 |
| 7601685 |
Growth factor modified protein matrices for tissue engineering |
Oct. 13, 2009 |
| 7601518 |
Secretion of neublastin |
Oct. 13, 2009 |
| 7601491 |
Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
Oct. 13, 2009 |
| 7601358 |
Mycobacterium tuberculosis protein composition |
Oct. 13, 2009 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
